The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H.

A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that ...

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota ...

Fred Hutch Cancer Center Senior Vice President and Director of the Clinical Research Division Sara Hurvitz, MD, recently received the inaugural Smith Family Endowed Chair in Women’s Health. The new ...

Tucked away in the Pacific Northwest, Fred Hutch Cancer Center blazed an unusual path when it opened its doors 50 years ago — one of the first eight new comprehensive centers authorized by the 1971 ...

A cancer diagnosis isn’t just scary. It can also be incredibly confusing. Not only do new cancer patients need blood tests and biopsies, they may also need scans and other imaging tests to stage the ...

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, ...

Many cancer drugs work by inhibiting the activity of proteins — the molecules that do most of the work in the cell. But some misbehaving proteins that turn normal cells cancerous are difficult to ...

The Clinical Research and Translational Science and Therapeutics Divisions are hosting a scientific symposium in honor of Dr. Rainer Storb on Friday, June 27, 2025. Dr. Storb has been a pivotal figure ...

Our mission is to provide patients with the highest quality, personalized care closer to home. As part of Fred Hutch, our community oncologists offer patients multidisciplinary tumor board opinions, ...